Added the EDRD csv Data files

EDRD-Data/CodeSet.csv

@@ -0,0 +1,95 @@
+Name,Code,CodeSetType,IsActive
+Atypical hemolytic uremic syndrome,789660001,SNOMED ID,TRUE
+Hemolytic anemia (disorder),61261009,SNOMED ID,TRUE
+Paroxysmal nocturnal hemoglobinuria (disorder),1963002,SNOMED ID,TRUE
+Cystic fibrosis (disorder),190905008,SNOMED ID,TRUE
+Spinal muscular atrophy (disorder),5262007,SNOMED ID,TRUE
+Juvenile neuronal ceroid lipofuscinosis (disorder),61663001,SNOMED ID,TRUE
+Mucopolysaccharidosis (disorder),11380006,SNOMED ID,TRUE
+Morquio syndrome (disorder),378007,SNOMED ID,TRUE
+Infantile hypophosphatasia (disorder),55236002,SNOMED ID,TRUE
+Hypophosphatemia (disorder),4996001,SNOMED ID,TRUE
+Cystinosis (disorder),190681003,SNOMED ID,TRUE
+Fabry's disease (disorder),16652001,SNOMED ID,TRUE
+Mucopolysaccharidosis type I-S (disorder),73123008,SNOMED ID,TRUE
+Mucopolysaccharidosis type I (disorder),75610003,SNOMED ID,TRUE
+Mucopolysaccharidosis type II (disorder),70737009,SNOMED ID,TRUE
+"Niemann-Pick disease, type C",66751000,SNOMED ID,TRUE
+Glucosylceramide beta-glucosidase deficiency (disorder),190794006,SNOMED ID,TRUE
+"Glycogen storage disease, type II (disorder)",274864009,SNOMED ID,TRUE
+Multisystem inflammatory syndrome in children (disorder),895448002,SNOMED ID,TRUE
+Familial amyloid nephropathy with urticaria AND deafness (disorder),15123008,SNOMED ID,TRUE
+Urticaria caused by cold (disorder),74774004,SNOMED ID,TRUE
+"Chronic infantile neurological, cutaneous and articular syndrome (disorder)",239826001,SNOMED ID,TRUE
+Amyloidosis (disorder),17602002,SNOMED ID,TRUE
+Polyneuropathy (disorder),42345000,SNOMED ID,TRUE
+Angioedema (disorder),41291007,SNOMED ID,TRUE
+Cardiomyopathy (disorder),85898001,SNOMED ID,TRUE
+Retinitis pigmentosa (disorder),28835009,SNOMED ID,TRUE
+Retinal dystrophy (disorder),314407005,SNOMED ID,TRUE
+Retinal disorder (disorder),29555009,SNOMED ID,TRUE
+Disorder of lipid metabolism (disorder),267431006,SNOMED ID,TRUE
+Lipid Storage disease (disorder),10741005,SNOMED ID,TRUE
+Carnitine palmitoyltransferase I deficiency (disorder),238001003,SNOMED ID,TRUE
+Carnitine palmitoyltransferase II deficiency (disorder),238002005,SNOMED ID,TRUE
+Carnitine palmitoyltransferase deficiency (disorder),90500005,SNOMED ID,TRUE
+Very long chain acyl-coenzyme A dehydraogenase deficiency (disorder),237997005,SNOMED ID,TRUE
+Mitochondrial trifunctional protein deficiency (disorder),237999008,SNOMED ID,TRUE
+Long chain acyl-coenzyme A dehydrogenease deficiency (disorder),237996001,SNOMED ID,TRUE
+Acute intermittent porphyria (disorder),234422006,SNOMED ID,TRUE
+Primary hyperoxaluria (disorder),17901006,SNOMED ID,TRUE
+Growth retardation (disorder),444896005,SNOMED ID,TRUE
+Thrombotic microangiopathy,M311,ICD-10,TRUE
+"Hereditary haemolytic anaemia, unspecified",D589,ICD-10,TRUE
+Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli],D595,ICD-10,TRUE
+"Cystic fibrosis, unspecified",E849,ICD-10,TRUE
+"Spinal muscular atrophy, unspecified",G129,ICD-10,TRUE
+Neuronal ceroid lipofuscinosis,E754,ICD-10,TRUE
+"Mucopolysaccharidosis, unspecified",E763,ICD-10,TRUE
+Other mucopolysaccharidoses,E762,ICD-10,TRUE
+Disorders of phosphorus metabolism and phosphatases,E833,ICD-10,TRUE
+Disorders of amino-acid transport,E720,ICD-10,TRUE
+Other sphingolipidosis,E752,ICD-10,TRUE
+"Mucopolysaccharidosis, type I",E760,ICD-10,TRUE
+"Mucopolysaccharidosis, type II",E761,ICD-10,TRUE
+Glycogen storage disease,E740,ICD-10,TRUE
+Multisystem inflammatory syndrome associated with COVID-19,U073,ICD-10,TRUE
+Non-neuropathic heredofamilial amyloidosis,E850,ICD-10,TRUE
+Urticaria due to cold and heat (ICD-10),L502,ICD-10,TRUE
+"Amyloidosis, unspecified",E859,ICD-10,TRUE
+"Polyneuropathy, unspecified",G629,ICD-10,TRUE
+Angioneurotic oedema (ICD-10),T783,ICD-10,TRUE
+"Cardiomyopathy, unspecified",I429,ICD-10,TRUE
+Hereditary retinal dystrophy,H355,ICD-10,TRUE
+"Retinal disorder, unspecified",H359,ICD-10,TRUE
+"Disorder of lipoprotein metabolism, unspecified",E789,ICD-10,TRUE
+"Lipid storage disorder, unspecified",E756,ICD-10,TRUE
+Disorders of fatty-acid metabolism,E713,ICD-10,TRUE
+Other porphyria,E802,ICD-10,TRUE
+Other specified disorders of carbohydrate metabolism,E748,ICD-10,TRUE
+"Short stature, not elsewhere classified",E343,ICD-10,TRUE
+Thrombotic microangioapathy,4446,ICD-9,TRUE
+"Hereditary haemolytic anaemias, unspecified",2829,ICD-9,TRUE
+Hemoglobinuria due to hemolysis from external causes,2832,ICD-9,TRUE
+Cystic fibrosis,2770,ICD-9,TRUE
+Spinal muscular atrophy,3351,ICD-9,TRUE
+Cerebral lipidoses,3301,ICD-9,TRUE
+Mucopolysaccharidosis,2775,ICD-9,TRUE
+Disorders of phosphorus metabolism,2753,ICD-9,TRUE
+Disturbances of amino-acid transport,2700,ICD-9,TRUE
+Lipidoses,2727,ICD-9,TRUE
+Glycogenosis,2710,ICD-9,TRUE
+"Viral infection in conditions classified elsewhere, other",798,ICD-9,TRUE
+Amyloidosis,2773,ICD-9,TRUE
+Urticaria due to cold and heat (ICD-9),7082,ICD-9,TRUE
+Other specified congenital anomalies,7598,ICD-9,TRUE
+"Hereditary and idiopathic peripheral neuropathy, unspecified",3569,ICD-9,TRUE
+Angioneurotic oedema (ICD-9),9951,ICD-9,TRUE
+Other primary cardiomyopathies,4254,ICD-9,TRUE
+Hereditary retinal dystrophies,3627,ICD-9,TRUE
+Unspecified retinal disorders,3629,ICD-9,TRUE
+"Disorders of lipoid metabolism, unspecified disorders of lipoid metabolism",2729,ICD-9,TRUE
+Other specified disorders of metabolism,2778,ICD-9,TRUE
+Disorders of porphyrin metabolism,2771,ICD-9,TRUE
+Lack of expected normal physiological development,7834,ICD-9,TRUE
+Other specified disorders of carbohydrate transport and metabolism,2718,ICD-9,TRUE

EDRD-Data/CodeSetBundle.csv

@@ -0,0 +1,27 @@
+RecordType,Name,CodeSet1.Name,CodeSet2.Name,CodeSet3.Name,CodeSet4.Name,CodeSet5.Name,CodeSet6.Name,CodeSet7.Name,CodeSet8.Name,CodeSet9.Name,CodeSet10.Name,CodeSet11.Name
+EDRD Code Set Bundle,atypical hemolytic uremic syndrome - aHUS,Atypical hemolytic uremic syndrome,Hemolytic anemia (disorder),Thrombotic microangiopathy,"Hereditary haemolytic anaemia, unspecified",Thrombotic microangioapathy,"Hereditary haemolytic anaemias, unspecified",,,,,
+EDRD Code Set Bundle,paroxysmal nocturnal hemoglobinuria - PNH,Paroxysmal nocturnal hemoglobinuria (disorder),Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli],Hemoglobinuria due to hemolysis from external causes,,,,,,,,
+EDRD Code Set Bundle,cystic fibrosis - CF,Cystic fibrosis (disorder),"Cystic fibrosis, unspecified",Cystic fibrosis,,,,,,,,
+EDRD Code Set Bundle,spinal muscular atrophy - SMA,Spinal muscular atrophy (disorder),"Spinal muscular atrophy, unspecified",Spinal muscular atrophy,,,,,,,,
+EDRD Code Set Bundle,neuronal ceroid lipofuscinosis type 2 - NCL,Juvenile neuronal ceroid lipofuscinosis (disorder),Neuronal ceroid lipofuscinosis,Cerebral lipidoses,,,,,,,,
+EDRD Code Set Bundle,mucopolysaccharidosis 4 - MPS4,Mucopolysaccharidosis (disorder),Morquio syndrome (disorder),"Mucopolysaccharidosis, unspecified",Other mucopolysaccharidoses,Mucopolysaccharidosis,,,,,,
+EDRD Code Set Bundle,hypophosphatasia - HPP,Infantile hypophosphatasia (disorder),Hypophosphatemia (disorder),Disorders of phosphorus metabolism and phosphatases,Disorders of phosphorus metabolism,,,,,,,
+EDRD Code Set Bundle,nephropathic cystinosis - cystinosis,Cystinosis (disorder),Disorders of amino-acid transport,Disturbances of amino-acid transport,,,,,,,,
+EDRD Code Set Bundle,Fabry disease - Fabry,Fabry's disease (disorder),Other sphingolipidosis,Lipidoses,,,,,,,,
+EDRD Code Set Bundle,severe primary insulin-like growth factor-1 deficiency - SPIGFD,Growth retardation (disorder),"Short stature, not elsewhere classified",Lack of expected normal physiological development,,,,,,,,
+EDRD Code Set Bundle,acute hepatic prophyria - AHP,Acute intermittent porphyria (disorder),Other porphyria,Disorders of porphyrin metabolism,,,,,,,,
+EDRD Code Set Bundle,lysosomal acid lipase deficiency - LAL-D,Disorder of lipid metabolism (disorder),Lipid Storage disease (disorder),"Disorder of lipoprotein metabolism, unspecified","Lipid storage disorder, unspecified","Disorders of lipoid metabolism, unspecified disorders of lipoid metabolism",Lipidoses,,,,,
+EDRD Code Set Bundle,transthyretin-mediated amyloidosis - cardiomyopathy - ATTR-CM,Amyloidosis (disorder),"Amyloidosis, unspecified",Amyloidosis,Cardiomyopathy (disorder),"Cardiomyopathy, unspecified",Other primary cardiomyopathies,,,,,
+EDRD Code Set Bundle,hereditary transthyretin-mediated amyloidosis - hATTR,Amyloidosis (disorder),Polyneuropathy (disorder),"Amyloidosis, unspecified","Polyneuropathy, unspecified",Amyloidosis,"Hereditary and idiopathic peripheral neuropathy, unspecified",,,,,
+EDRD Code Set Bundle,x-linked hypophosphataemia - XLH,Hypophosphatemia (disorder),Disorders of phosphorus metabolism and phosphatases,Disorders of phosphorus metabolism,,,,,,,,
+EDRD Code Set Bundle,hereditary angioedema - HAE,Angioedema (disorder),Angioneurotic oedema (ICD-9),Angioneurotic oedema (ICD-10),,,,,,,,
+EDRD Code Set Bundle,mucopolysaccharidosis II - MPS2,Mucopolysaccharidosis (disorder),Mucopolysaccharidosis type II (disorder),"Mucopolysaccharidosis, unspecified",Mucopolysaccharidosis,"Mucopolysaccharidosis, type II",,,,,,
+EDRD Code Set Bundle,mucopolysaccharidosis 6 - MPS6,Mucopolysaccharidosis (disorder),"Mucopolysaccharidosis, unspecified",Mucopolysaccharidosis,,,,,,,,
+EDRD Code Set Bundle,Niemann-Pick type C disease - NPC,"Niemann-Pick disease, type C",Other sphingolipidosis,Lipidoses,,,,,,,,
+EDRD Code Set Bundle,Gaucher disease type 1 - Gaucher,Glucosylceramide beta-glucosidase deficiency (disorder),Other sphingolipidosis,Lipidoses,,,,,,,,
+EDRD Code Set Bundle,Pompe disease - Pompe,"Glycogen storage disease, type II (disorder)",Glycogen storage disease,Glycogenosis,,,,,,,,
+EDRD Code Set Bundle,mucopolysaccharidosis I - MPS1,Mucopolysaccharidosis type I-S (disorder),Mucopolysaccharidosis (disorder),Mucopolysaccharidosis type I (disorder),"Mucopolysaccharidosis, type I","Mucopolysaccharidosis, unspecified",Mucopolysaccharidosis,,,,,
+EDRD Code Set Bundle,cryopyrin-associated periodic syndromes - CAPS,Multisystem inflammatory syndrome in children (disorder),Familial amyloid nephropathy with urticaria AND deafness (disorder),Urticaria caused by cold (disorder),"Chronic infantile neurological, cutaneous and articular syndrome (disorder)",Multisystem inflammatory syndrome associated with COVID-19,Non-neuropathic heredofamilial amyloidosis,Urticaria due to cold and heat (ICD-9),"Viral infection in conditions classified elsewhere, other",Amyloidosis,Urticaria due to cold and heat (ICD-10),Other specified congenital anomalies
+EDRD Code Set Bundle,inherited retinal dystrophy (RPE65 mutations) - IRD,Retinitis pigmentosa (disorder),Retinal dystrophy (disorder),Retinal disorder (disorder),Hereditary retinal dystrophy,"Retinal disorder, unspecified",Hereditary retinal dystrophies,Unspecified retinal disorders,,,,
+EDRD Code Set Bundle,long-chain fatty acid oxidation disorders - LC-FAOD,Carnitine palmitoyltransferase I deficiency (disorder),Carnitine palmitoyltransferase II deficiency (disorder),Carnitine palmitoyltransferase deficiency (disorder),Very long chain acyl-coenzyme A dehydraogenase deficiency (disorder),Mitochondrial trifunctional protein deficiency (disorder),Long chain acyl-coenzyme A dehydrogenease deficiency (disorder),Disorders of fatty-acid metabolism,Other specified disorders of metabolism,,,
+EDRD Code Set Bundle,primary hyperoxaluria type 1 - PH1,Primary hyperoxaluria (disorder),Other specified disorders of carbohydrate metabolism,Other specified disorders of carbohydrate transport and metabolism,,,,,,,,

EDRD-Data/Manufacturer Account.csv

@@ -0,0 +1,19 @@
+Account Name,RecordType
+Akcea Therapeutics Inc.,Manufacturer
+Alexion Pharma GMBH,Manufacturer
+Alnylam Netherlands B.V.,Manufacturer
+Amicus Therapeutics Canada Inc.,Manufacturer
+Biogen Canada Inc.,Manufacturer
+BioMarin International Limited,Manufacturer
+Hoffmann-La Roche Limited,Manufacturer
+Horizon Therapeutics Ireland Dac,Manufacturer
+Ipsen Biopharmaceuticals Canada Inc.,Manufacturer
+Kyowa Kirin Inc.,Manufacturer
+Novartis Pharmaceuticals Canada Inc.,Manufacturer
+Pfizer Canada ULC,Manufacturer
+Sandoz Canada Incorporated,Manufacturer
+Sanofi-Aventis Canada Inc.,Manufacturer
+Takeda Canada Inc.,Manufacturer
+Ultragenyx Pharmaceutical Inc.,Manufacturer
+Vertex Pharmaceuticals (Canada) Incorporated,Manufacturer
+Swedish Orphan Biovitrum AB (Publ),Manufacturer

EDRD-Data/MedicalDiagnosis.csv

@@ -0,0 +1,36 @@
+HealthcareDiagnosis,Medication
+acute hepatic prophyria - AHP,givosiran
+atypical hemolytic uremic syndrome - aHUS,eculizumab-aHUS
+cryopyrin-associated periodic syndromes - CAPS,canakinumab
+cystic fibrosis - CF,ivacaftor
+cystic fibrosis - CF,elexacaftor/tezacaftor/ivacaftor
+Fabry disease - Fabry,migalastat
+Fabry disease - Fabry,agalsidase alfa
+Fabry disease - Fabry,agalsidase beta
+Gaucher disease type 1 - Gaucher,velaglucerase alfa
+Gaucher disease type 1 - Gaucher,miglustat-Gaucher
+hereditary angioedema - HAE,lanadelumab
+hereditary transthyretin-mediated amyloidosis - hATTR,patisiran
+hereditary transthyretin-mediated amyloidosis - hATTR,inotersen
+hypophosphatasia - HPP,asfotase alfa
+inherited retinal dystrophy (RPE65 mutations) - IRD,voretigene neparvovec
+long-chain fatty acid oxidation disorders - LC-FAOD,triheptanoin
+lysosomal acid lipase deficiency - LAL-D,sebelipase alfa
+mucopolysaccharidosis 4 - MPS4,elosulfase alfa
+mucopolysaccharidosis 6 - MPS6,galsulfase
+mucopolysaccharidosis I - MPS1,laronidase
+mucopolysaccharidosis II - MPS2,idursulfase
+nephropathic cystinosis - cystinosis,cysteamine
+neuronal ceroid lipofuscinosis type 2 - NCL,cerliponase alfa
+Niemann-Pick type C disease - NPC,miglustat-NPC
+paroxysmal nocturnal hemoglobinuria - PNH,eculizumab-PNH
+Pompe disease - Pompe,alglucosidase alfa
+severe primary insulin-like growth factor-1 deficiency - SPIGFD,mecasermin
+spinal muscular atrophy - SMA,nusinersen
+spinal muscular atrophy - SMA,risdiplam
+spinal muscular atrophy - SMA,onasemnogene abeparvovec
+transthyretin-mediated amyloidosis - cardiomyopathy - ATTR-CM,tafamidis - Vyndamax
+transthyretin-mediated amyloidosis - cardiomyopathy - ATTR-CM,tafamidis - Vyndaqel
+x-linked hypophosphataemia - XLH,burosumab
+primary hyperoxaluria type 1 - PH1,lumasiran
+paroxysmal nocturnal hemoglobinuria - PNH,pegcetacoplan